CLINICAL_TRIALS
trial_result
· 2014-03-19
Clinical Trial Update: Cross-Over Study of Sevelamer Hydrochloride and Sevelamer Carbonate [Phase 2]
Summary
A Phase 2 crossover trial comparing sevelamer hydrochloride and sevelamer carbonate in chronic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Chronic Kidney Disease | Phase 2 | Status: COMPLETED